There are currently 298 active clinical trials seeking participants for Cancer research studies. The states with the highest number of trials for Cancer participants are California, Texas, New York and Florida.
Testicular Tissue Cryopreservation in Children
NCT02872532
Recruiting
This protocol is being designed to offer testicular tissue cryopreservation to male pediatric patients (0-17 years of age) with fertility threatening medical diagnoses or facing surgery, chemotherapy or radiation therapy that may cause loss of reproductive potential.
Gender:
Male
Ages:
Between 0 years and 17 years
Trial Updated:
11/27/2023
Locations: Mayo Clinic in Rochester, Rochester, Minnesota
Conditions: Cancer
Register for Updates
Screening for Atrial Fibrillation in Patients With Cancer: A Pilot Randomized Controlled Clinical Trial
NCT05784766
Recruiting
Patients with cancer have a higher incidence of AF but despite the higher incidence of AF in the cancer population, there are no randomized controlled trials (RCTs) for AF screening in this population. RCTs of AF screening in the general population have shown that screening can effectively detect AF earlier, and helps to identify candidates for appropriate anticoagulation that may lead to improvement in clinical outcomes.
Gender:
All
Ages:
Between 65 years and 90 years
Trial Updated:
11/20/2023
Locations: University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
Conditions: Cancer
Register for Updates
Prevent Cancer- Greenville
NCT04947098
Recruiting
Prevent Cancer-Greenville was created to provide individuals with the opportunity to have their risk of developing cancer studied. Some individuals may be at a higher risk due to their personal lifestyle, family history and/or exposures. If subjects are found to be at high risk for developing a disease, they will be sent to a healthcare provider for further care.
Gender:
All
Ages:
18 years and above
Trial Updated:
11/16/2023
Locations: Prisma Health-Upstate, Greenville, South Carolina
Conditions: Cancer, High-Risk Cancer
Register for Updates
Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma
NCT05145400
Recruiting
This research study is investigating the safety and effectiveness of using combination of isatuximab, lenalidomide and dexamethasone for the treatment of newly diagnosed multiple myeloma (MM). The study team will use lower doses than is currently standard for these drugs. Lower doses will be used to avoid or possibly reduce any unwanted side effects commonly associated with these drugs. Using lower doses of the combination isatuximab, lenalidomide and dexamethasone, has not been approved by the... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
11/14/2023
Locations: University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina +2 locations
Conditions: Multiple Myeloma, Cancer
Register for Updates
Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint Inhibitors
NCT04615988
Recruiting
The purpose of this research study is to see if the amount of vitamin D in ones blood makes it more or less likely to develop thyroid gland toxicity when being treated with immunotherapy that blocks the activity of proteins called programed death-1(PD-1) or programmed death ligand-1 (PD-L1). Immunotherapy is treatment that makes changes to the immune system to try to fight cancer. Immunotherapy treatments that block the activity of important parts of the immune system called PD-1 and PD-L1 are u... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
11/13/2023
Locations: Mount Sinai Hospital /Tisch Cancer Cancer/Ruttenberg Treatment Center, New York, New York
Conditions: Thyroid, PD-1, Cancer
Register for Updates
Improving Outcomes for Older Adults Undergoing Radiation Therapy
NCT05721053
Recruiting
The purpose of this study is to improve healthcare received by people ≥ 65 years who are receiving radiation therapy (RT). The study will primarily examine patients ability to complete RT, changes in a patients' daily function and self-reported toxicities. To collect this information, study participants will be asked to complete surveys and physical and cognitive function assessments at five different timepoints in their treatment: before RT, End of RT, and at 1, 3, and 6 months follow up visits... Read More
Gender:
All
Ages:
65 years and above
Trial Updated:
11/13/2023
Locations: One Gustave L Levy Place, New York, New York
Conditions: Cancer, Radiation Therapy
Register for Updates
Risk Factors, Clinical Characteristics and Outcomes of Acute Infection With Coronavirus 2019 (COVID-19) In Children
NCT04371315
Recruiting
Patient are being asked to provide respiratory and blood samples for a clinical research study because the patients have a virus called the novel coronavirus, or SARS-CoV-2, that causes the disease known as Covid-19. Investigators do not know a lot about this virus, including all the ways it travels from person to person. Investigators also do not know if a person will get sick or not from the virus after being in close contact with someone who has the virus. Because of this, investigators are... Read More
Gender:
All
Ages:
24 years and below
Trial Updated:
11/09/2023
Locations: St. Jude Children's Research Hospital, Memphis, Tennessee
Conditions: Corona Virus Infection, Pediatric Cancer, Adult Children, Cancer
Register for Updates
Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies
NCT03089554
Recruiting
This is a substudy (Part 2) of a larger two-part clinical trial including both observational and therapeutic (interventional) cohorts to assess the progression free survival ratio of patients treated with a targeted therapy based on genomic analysis results and recommendation by the Markey Cancer Center Molecular Tumor Board (MCC MTB).
Gender:
All
Ages:
18 years and above
Trial Updated:
11/08/2023
Locations: Markey Cancer Center, University of Kentucky, Lexington, Kentucky
Conditions: Cancer
Register for Updates
Identification of Pathways to Mitigate Immune-Related Adverse Events With Cancer Immunotherapy
NCT04283539
Recruiting
This protocol is a prospective, observational study of participants receiving immunotherapy (checkpoint inhibitors, CPI) for cancer therapy, testing the hypothesis that patients with immune related cutaneous adverse events (ircAEs) have unique immunologic endotypes associated with polarized immune responses.
Gender:
All
Ages:
18 years and above
Trial Updated:
11/08/2023
Locations: National Jewish Health, Denver, Colorado +2 locations
Conditions: Cancer
Register for Updates
Chinese American Cancer Survivors Writing Study
NCT05456100
Recruiting
The Chinese American Cancer Survivors Writing Study is a Randomized Controlled Trial (RCT) testing the feasibility and efficacy of the Expressive Helping (EH) intervention among Chinese American cancer survivors.
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
11/07/2023
Locations: New York University, New York, New York
Conditions: Cancer
Register for Updates
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
NCT03213002
Recruiting
The purpose of this study is to evaluate the safety and efficacy of administering the medication capecitabine along with temozolomide when you start your monthly regimen of oral temozolomide for the treatment of your newly diagnosed glioblastoma multiforme (GBM). Capecitabine is an oral chemotherapy that is given to patients with other types of cancer. The study will evaluate whether the dosage of 1500 mg/m2 of capecitabine is tolerable after radiation, when taken along with temozolomide. It wi... Read More
Gender:
All
Ages:
Between 18 years and 74 years
Trial Updated:
11/07/2023
Locations: Lenox Hill Brain Tumor Center, New York, New York
Conditions: Glioblastoma Multiforme (GBM), Glioblastoma, Glioma of Brain, Glioblastoma, Adult, Brain Tumor, Brain Tumor, Primary, Brain Tumor Adult, Cancer, Brain Cancer
Register for Updates
Solid Tumor Imaging MR-Linac (STIM Study)
NCT03500081
Recruiting
The use of MRI imaging and image fusion in radiation therapy has dramatically increased during the past decade. However, the existing MRI-imaging protocols, imaging software and pulse sequences are all optimized for diagnostic purposes. With the introduction of the MR-linac, there is a critical and imminent need to develop imaging protocols that build and adapt the existing imaging parameters within the scope of the FDA-approved software to acquire MRI images that have less geometric distortion... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
11/07/2023
Locations: Froedtert & the Medical College of Wisconsin, Milwaukee, Wisconsin
Conditions: Cancer
Register for Updates